Fritextsökning
Innehållstyper
-
Oväntat stort mörkertal för TBE-infektioner – ”Vi blev väldigt överraskade”
En ny studie tyder på att infektioner av det fästingburna TBE-viruset är långt vanligare i Sverige än man hittills trott.
-
Cytel Inc acquires the SDS Group
The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...
-
Swedish and Danish Life Science – are there still untapped synergies?
With the increasing developments in life sciences over the past decade and strong support for the sector’s strategic importance from both the Sweden and Danish ...
-
Novavax is developing a vaccine candidate against Covid-19 and seasonal flu
A combined vaccine against both Covid-19 and seasonal flu is showing promising results in studies, according to the American drug developer Novavax. The adjuvan...
-
The pandemic caused a reshuffle among the world’s vaccine giants – here is the new top list
Fuelled by the pandemic, the power balance in the global vaccine market has completely changed in recent years, a survey from Fierce Pharma shows
-
FOKUS Patient turns international
FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.
-
BioVentureHub CEO: “Companies with a high degree of interaction achieve greater success”
For the first time since its inception, AstraZeneca’s BioVentureHub can now recruit new companies, as some of its tenants have grown significantly and are leavi...
-
Anna Törner: Kalashnikovs in a new guise
Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...
-
Paolo Macchiarini in court – “The sole intent was to cure”
Paolo Macchiarini’s surgical procedure was illegal, life-threatening and caused severe and prolonged suffering to patients the prosecution claimed when the tria...
-
Marie Gårdmark: New incentives for orphan products on its way
"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...
-
Study: Our behaviour may have been guided by wishful thinking during the pandemic
A new study suggests that we systematically underestimate health risks if and when it suits us. This was especially true during the pandemic, as our risk assess...
-
Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap
From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered b...
-
Göran Stiernstedt: “We are the world’s worst at continuity”
Failed investments in primary care, an unreasonable system with online doctors and a public failure at coordinating the healthcare IT system. Göran Stiernstedt ...
-
Promising Alzheimer’s study data sends Bioarctic stock soaring
The drug candidate lecanemab from Swedish company Bioarctic significantly slowed down the deterioration in patients with early on-set Alzheimer’s, according to ...
-
Giulia Gaudenzi: ”Key lessons from global health research”
The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.
-
Värdet av en deltidskonsult inom Medical Affairs
Johanna Repits är Head of Medical Solutions på Scientific Solutions Scandinavia AB. Här delar hon sina tankar kring fördelarna med att ta in en Medical-konsult ...
-
IVI’s Director General on establishing in Sweden: Will need up to 40 employees
The International Vaccine Institute, IVI, hopes to have its first staff on-site in Stockholm within a couple of months, says the institute’s Director General Je...
-
Start-up developing ”digital twin” received award during the EIT Health Summit
A biotech company, a medtech company and a company in digital health were on the podium when the EIT Health Catapult awarded its winners.
-
When carelessness, forgetfulness and coincidence become the researcher’s best friend
Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advanc...
-
A growing industry in Denmark: “One new life science company a week”
The life science sector in eastern Denmark continues to grow in the number of employees, as well as the number of companies. An emerging problem is the shortage...
-
Swedish-Danish meeting at Medicon Village: “One of the most important life science congresses”
For the eleventh year, The Future of Swedish and Danish Life Science was held on Wednesday, and the event continues to function as a connecting link between the...
-
Investments worth 40 billion in the Öresund region – “A huge investment wave”
A new report reveals that medical companies in the Oresund region are investing like never before.
-
Upcoming event: New updates on drugs
At Medicon Valley Alliance venues in Copenhagen/Örestad April 1 2020 the meeting New updates in Drug Formulation & Bioavailability takes place for the for the eighth time.
-
Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation
A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure t...